India: Dr. Reddy's Gets 4 Observations from USFDA for Telangana Plant
Dr. Reddy’s Laboratories has said that the US health regulator had issued four observations after inspecting its active pharmaceutical ingredients (API) facility in Telangana. “The audit of our API Hyderabad plant 1 at Jinnaram Mandal, Medak district, Telangana, by the USFDA has been completed. We have been issued a Form 483 with four observations, which will be addressed comprehensively within stipulated time,” Dr. Reddy’s said in a regulatory filing.
According to the USFDA, a Form 483 is issued to a firm’s management at the conclusion of an inspection when investigator has observed any condition that in its judgement may constitute a violation of the Food Drug and Cosmetic (FD&C) Act and related Acts. It notifies the company’s management of objectionable conditions.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
Retatrutide Powder Lyophilized Hypoglycemic Tirzepatide Cagrilintide Nad+ Melanotan Mt2 for Weight Loss Peptides
$194.75/MT FOB
2026-07-18
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
India Launches Anti-Dumping Probe into PET Film from China, Singapore, Thailand and the UAE
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
India Imposes Final Anti‑Dumping Duties on Ethylenediamine from China, EU, Saudi Arabia, and Taiwan, China, with Top Rate of $575/tonne
-
FDA approves bemotrizinol, a long-used UV filter, for U.S. sunscreens
-
Urea Prices Surge as India Faces Critical Shortages: Will China’s Export Quotas Provide Relief?
-
India Extends Anti-Dumping Duties on Aniline Imports from China for Five More Years
-
Covestro India and CSIR-NCL Collaborate to Transform Polyurethane Waste
-
The United States Lifts Restrictions on Ethane Exports to China, and Trade Relations Show Signs of Easing
-
India Imposes Anti-Dumping Duties on Chinese vitamin A Palmitate and Insoluble Sulfur Products
-
Indian Government Increases Excise Duty on Petrol and Diesel
Recommend Reading
-
FDA Fast-Tracks U.S. Drug Manufacturing
-
India’s Pharma Cost Problem Gets Worse
-
India Targets Fake Drug Packaging
-
FDA Warning Letters Put GMP Back in Focus
-
A Faster Route to Diabetes Drug Chemistry
-
Positive Support, Palm Oil Prices Set to Rise
-
Bivalirudin: Medical Uses, Properties, and Safety
-
Chevron Phillips Chemical Completes Low-Viscosity PAO Expansion in Belgium
-
Avril Group to Acquire Champlor Renewables from Valtris
-
Japan Begins Construction of the World’s Largest Commercial Liquid Hydrogen Receiving Terminal